SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Acorda Therapeutics Inc.
An SI Board Since October 2003
Posts SubjectMarks Bans Symbol
120 6 0 ACOR
Emcee:  michael_f_murphy Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
95reuters.com Interesting news and late in the article there is the mention of ACArthur Radley-11/2/2009
94Acorda Therapeutics Announces Extension of Fampridine-SR PDUFA Goal Date to JanuIRWIN JAMES FRANKEL110/22/2009
93Good call :-)DewDiligence_on_SI-10/22/2009
92OT-Smart people are not immune to being stupid. I am guessing that ACOR stays kenhott-10/21/2009
91Lets hope that Galleon has already sold all of their ACOR shares.........appearsArthur Radley-10/21/2009
90Galleon is selling into the market. It certainly is not helping ACOR but Galleokenhott-10/21/2009
89Appears that the Galleon Fund...one where the head honcho was arrested for insidArthur Radley-10/20/2009
88The patent has been in the system for like 4 years so maybe the USPTO also thinkkenhott-10/20/2009
87That's unbelievable if a company can get a patent for a new type of responderkrw-10/20/2009
86<reply> No that was a typo, I wish it was that low! Market is in a show kenhott-10/20/2009
85Robert Steyer October 15, 2009 Acorda Therapeutics (Nasdaq: ACOR) illustrates wArthur Radley-10/15/2009
84Stock is up more than $8.00 in Pre-M. For those who held on during this period..Arthur Radley-10/15/2009
83<reply> Sometimes you are the goat and sometimes you are the taog. I am kenhott-10/15/2009
82This was a critical vote today...... "The Committee also recommended by a Arthur Radley-10/14/2009
8112-1 panel vote FOR efficacy!!!! Now complete the process with approval.Arthur Radley-10/14/2009
80HAWTHORNE, NY (TheStreet) -- The FDA advisory panel discussing Acorda TherapeutiArthur Radley-10/14/2009
79finance.yahoo.com Ken,The timing of this event is uncanny!Arthur Radley-10/13/2009
78Thanks AR and IJ for you inputs. The power of the group can not be under estimakenhott-10/13/2009
77I read it too. It had a persistently negative tone: - even with an SPA FDA musIRWIN JAMES FRANKEL110/12/2009
76<<<You must be a masochist>> "Twas a cold and dreary night.Arthur Radley-10/12/2009
75<the 177 (page) report> You must be a masochist. I had speed read the pakenhott-10/12/2009
74I waded through the 177 report over the weekend........didn't have the same Arthur Radley-10/12/2009
73So given enough time, all your questions will be answered. It turns out the quekenhott210/12/2009
72Isn't Wolfe the constant thorn in the side of the FDA? One can dream that mArthur Radley-10/9/2009
71>>Sidney Wolfe is on the panel. D*** :-( ij BTW - No financial interesIRWIN JAMES FRANKEL110/9/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):